Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Cash flows from operating activities      
Net income (loss) $ (150,136,000) $ (31,019,000) $ 107,568,000
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation 42,551,000 42,943,000 42,299,000
Use of restricted cash and cash equivalents 75,060,000 0 0
Non-cash LNG inventory—affiliate write-downs 0 10,600,000 0
Amortization of debt discount 4,695,000 4,695,000 4,695,000
Amortization of debt issuance costs 4,362,000 4,382,000 4,863,000
Non-cash derivative loss (619,000) (195,000) 124,000
Loss on early extinguishment of debt (1,470,000) 0 0
Other 3,496,000 0 0
Changes in operating assets and liabilities:      
Accounts and interest receivable 481,000 853,000 (626,000)
Accounts receivable—affiliate (1,677,000) 384,000 2,874,000
Accounts payable and accrued liabilities 1,960,000 (1,173,000) 3,035,000
Accounts payable and accrued liabilities—affiliate 2,412,000 (1,640,000) 2,566,000
Deferred revenue—affiliate 8,000 15,000 (62,833,000)
Deferred revenue (4,089,000) (3,964,000) (3,864,000)
Advances to affiliate (4,764,000) 2,851,000 1,815,000
LNG inventory—affiliate (51,000) (14,969,000) 0
Other (1,373,000) 486,000 1,621,000
Net cash provided by operating activities (26,214,000) 14,249,000 104,137,000
Cash flows from investing activities      
Use of restricted cash and cash equivalents 1,114,742,000 0 0
LNG terminal construction-in-process (1,118,457,000) (7,137,000) (4,955,000)
Advances under long-term contracts (740,000) (1,054,000) (121,000)
Net cash used in investing activities (4,455,000) (8,191,000) (5,076,000)
Cash flows from financing activities      
Proceeds from sale of Class B units, net 1,887,342,000 0 0
Proceeds from 2020 Notes 420,000,000 0 0
Proceeds from Liquefaction Credit Facility 100,000,000 0 0
Proceeds from sale of partnership units 250,022,000 70,157,000 0
Distributions to unitholders (57,821,000) (48,149,000) (163,249,000)
Proceeds from sale of partnership units 11,100,000 9,000,000  
Use of (investment in) restricted cash and cash equivalents (1,458,619,000) 0 0
Repayment of 2013 Notes (550,000,000) 0 0
Debt issuance costs (222,378,000) 0 0
Other 0 0 (5,000)
Net cash used in financing activities 368,546,000 22,008,000 (163,254,000)
Net increase (decrease) in cash and cash equivalents 337,877,000 28,066,000 (64,193,000)
Cash and cash equivalents—beginning of period 81,415,000 53,349,000 117,542,000
Cash and cash equivalents—end of period $ 419,292,000 $ 81,415,000 $ 53,349,000